Evidence map›Paper›PMID 36314839›Full record

ArticlemBio2022

ABHD16A Negatively Regulates the Palmitoylation and Antiviral Function of IFITM Proteins.

Xuemeng Shi, Xiaoling Li, Zhao Xu, Lingyi Shen, Yunyun Ding, Shuaiwu Chen, Lin Mao, Wei Liu, Jun Xu

Open access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. The Phospholipase AJournal of lipid and atherosclerosis · 2026
    Review
  4. Biochemistry · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Xuemeng Shi *College of Life Sciences, Henan Agricultural Universitygrid.108266.b, Zhengzhou, China.ORCID 0000-0002-5178-3725
Xiaoling Li *College of Life Sciences, Henan Agricultural Universitygrid.108266.b, Zhengzhou, China.
Zhao Xu *College of Life Sciences, Henan Agricultural Universitygrid.108266.b, Zhengzhou, China.
Lingyi ShenCollege of Life Sciences, Henan Agricultural Universitygrid.108266.b, Zhengzhou, China.
Yunyun DingCollege of Life Sciences, Henan Agricultural Universitygrid.108266.b, Zhengzhou, China.
Shuaiwu ChenCollege of Life Sciences, Henan Agricultural Universitygrid.108266.b, Zhengzhou, China.
Lin MaoCollege of Life Sciences, Henan Agricultural Universitygrid.108266.b, Zhengzhou, China.
Wei LiuCollege of Life Sciences, Henan Agricultural Universitygrid.108266.b, Zhengzhou, China.
Jun XuCollege of Life Sciences, Henan Agricultural Universitygrid.108266.b, Zhengzhou, China.ORCID 0000-0002-9255-0434
Henan Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interferon-inducible transmembrane (IFITM) proteins are small homologous proteins that are encoded by the interferon-stimulated genes (ISGs), which can be strongly induced by interferon (IFN) and provide resistance to invasion by a variety of viral pathogens. However, the exact molecular mechanisms underlying this function have remained elusive. The antiviral activity of IFITMs from different species depends on S-palmitoylation at conserved cysteine residues. However, specific enzymes involved in the dynamic palmitoylation cycle of IFITMs, especially depalmitoylase, have not yet been reported. Here, we demonstrate that α/-hydrolase domain-containing 16A (ABHD16A) is a depalmitoylase and a negative regulator of IFITM protein that can catalyze the depalmitoyl reaction of S-palmitoylated IFITM proteins, thereby decreasing their antiviral activities on RNA viruses. Using the acyl-PEGyl exchange gel shift (APEGS) assay, we identified ABHD16A proteins from humans, pigs, and mice that can directly participate in the palmitoylation/depalmitoylation cycles of IFITMs in the constructed

Indexed as

InterferonsVirus DiseasesAnimalsAntiviral AgentsCell LineHumansLipoylationMembrane ProteinsMiceMonoacylglycerol LipasesSwineABHD16A protein, humanABHD16A protein, mouseAntiviral AgentsInterferonsMembrane ProteinsMonoacylglycerol LipasesABHD16Aantiviral effectdepalmitoylaseIFITM proteinsJEVS-palmitoylation

Identifiers

PMID36314839
PMCPMC9765265
OpenAlexW4307773577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.